Capricor surges on plan to amend DMD filing after adcom setback on August 14, 2026 amendment Blackfoot language Capricor Therapeutics Cardiomyopathies Clinical action CTNNA2 gene deramiocel DMD Muscular Dystrophy, Duchenne PDUFA surge upper limb function +
Capricor Shares Plunge After FDA Says DMD Therapy Lacks Efficacy Ahead of Advisory Committee Meeting on July 28, 2026 Advisory Committees Blackfoot language Capricor Therapeutics Cardiomyopathies CTNNA2 gene deramiocel Effectiveness HOPE-3 Muscular Dystrophy, Duchenne plunge United States Food and Drug Administration +